Indeed, a study showed that DNMT inhibition can radiosensitize cancer cell lines, including glioma cells, by impairing cell cycle checkpoints and DNA repair capacity (Wee et al., 2021) (though this was not GBM-specific, it aligns with general principles). This evidence concerns the gene DNMT1 and cancer.